Ebola Bundibugyo reaches Europe: France confirms first case as DRC surpasses 1,000

Summary

DRC's Ministry of Health detected an outbreak of Bundibugyo ebolavirus (Orthoebolavirus bundibugyoense) in Ituri Province; WHO declared a PHEIC on 17 May 2026. As of 23 June: 1,094 confirmed DRC cases and 277 deaths; 20 Uganda cases (Kampala travellers from DRC), 2 deaths. Ituri Province accounts for over 90% of DRC cases across 22 health zones; North Kivu adds 94 cases. On 24 June, France confirmed its first case, a humanitarian doctor who flew commercially from Kinshasa while nearly asymptomatic, carrying headaches; now in strict isolation at a designated facility. This is the 17th Ebola outbreak in DRC and the second-largest ever globally. No licensed vaccine or specific treatment exists for the Bundibugyo strain; all approved countermeasures target Zaire ebolavirus. WHO and Africa CDC launched a joint six-month response plan targeting US$518M; over $910M was pledged at the 18 June Africa CDC heads-of-state briefing.

The split

The WHO-Africa CDC partnership is emphasising funding adequacy and a common response architecture. But CIDRAP and independent biosecurity assessors stress the vaccine gap as the structural difference between this outbreak and the 2018–20 DRC Zaire outbreak (where ring vaccination eventually contained it): there is simply no ring-vaccination tool for Bundibugyo. The Ituri conflict zone, hosting nearly one million displaced people, replicates the access conditions that prolonged the 2018-20 outbreak. MSF and Doctors Without Borders warn that treatment-centre shortages of medicines, ambulance fuel and staffing already constrain the response.

By the numbers

• 1,094 DRC confirmed cases, 277 deaths, as of 23 June 2026.
• 20 Uganda cases, 2 deaths, all Kampala travellers from DRC.
• 1 France case, humanitarian doctor, commercial flight from Kinshasa, confirmed 24 June.
• 1 Germany case, US citizen medically evacuated, May 19.
• Ituri Province, 997 cases (91%+) across 22 health zones; North Kivu, 94 cases.
• 17th, DRC Ebola outbreak; 2nd largest globally.
• 0, licensed vaccines or specific treatments for Bundibugyo ebolavirus.
• $518M, six-month WHO-Africa CDC response plan target; $910M+ pledged.

Why it matters

The absence of an approved vaccine converts this from a manageable ring-vaccination problem into an outbreak-containment problem in a conflict zone, the same conditions that produced the 2018-20 extended crisis. A disease contained to DRC and Uganda for now, but with a history of cross-border spread and no prophylactic tool, is a live global PHEIC with no clear exit strategy beyond case-by-case management and experimental treatment.

What to watch

• Whether any Bundibugyo-specific vaccine or treatment enters emergency use authorisation.
• Whether the France case produces secondary transmission (contact tracing is ongoing for 300+ flight contacts).
• Uganda transmission chain, whether Kampala community spread develops beyond travel-linked cases.
• Whether the Ituri conflict zone remains accessible to response teams.
• Funding materialising from the $910M pledge vs. the $518M plan.